Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The TB vaccine market is experiencing notable developments in the recent past with its trends. At present, tuberculosis disease caused by a bacteria as it primarily affects the lungs remains a worldwide health concern. Hence, there is an increased effort on vaccine research and development. In response to this challenge, pharmaceutical companies are teaming up with research institutions and government agencies to address TB prevention and treatment.
One of the important trends is an increase in investment in research and development, which leads to accessible and more efficient TB vaccines. Consequently, these organizations have committed significant resources towards accelerating progress on new vaccines due to increasing demand for improved preventive measures. Therefore, this has resulted into a pipeline of promising candidates at various stages of clinical trials thereby reflecting a positive outlook for the market. Besides that, public private partnerships (PPP) have emerged as one of the methods through which TB vaccine development can be facilitated.
Another trend includes increased global awareness and advocacy for TB immunization programs. Both governments and international non-governmental organizations (NGOs) have embarked on campaigns meant to educate communities on how best they can prevent themselves from acquiring TB infection through immunization practices among others. The outcome of this heightened knowledge base is greater demand for tuberculosis vaccinations especially in areas where it is highly prevalent. As such there has been a move towards putting emphasis on prevention through immunization rather than traditional treatment options.
Other market trends include interest in differentiated vaccine strategies like booster doses or combination vaccines. Currently researchers are working towards improving efficacy rates of these vaccines while prolonging their protection time periods;thereby making them available beyond five years if possible.Attempts are being made to improve MDGs performance by using additional “inactive” components.The next step was the analysis of medical history data collected between 2002-2010.Additionally , because some vaccines weaken over time , boosters have been looked at as a way out.Furthermore , efforts are underway towards developing combo vaccines focusing on multiple strains or diseases as a more comprehensive strategy against infectious diseases.
Furthermore, regulatory support and initiatives are shaping the landscape of the TB vaccine treatment market. Regulatory agencies are actively engaging with stakeholders to streamline the approval processes for new vaccines. This collaborative approach is designed to ensure that innovative TB vaccines are introduced into the market rapidly while meeting safety and efficacy requirements. Also, there are government –sponsored initiatives which give financial incentives and support for developing and distributing TB vaccines thus making the market grow faster.”
Tuberculosis Vaccine Treatment Market Highlights:
Tuberculosis Vaccine Treatment Market Overview
Tuberculosis Vaccine Treatment Market Size was valued at USD 63.11 Billion in 2023. The Global Tuberculosis Vaccine Treatment industry is projected to grow from USD 65.51 Billion in 2024 to USD 88.28 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.38% during the forecast period (2024 - 2032).Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB).
Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
The vaccines trigger a potent immune response against infectious diseases; tuberculosis (TB) vaccines prevent infection with tuberculosis. Robert Koch was first to propose immunotherapy as a defense mechanism against TB. Currently, the only effective tuberculosis vaccine is BCG (Bacilli Calmette-Guerin).
Increasing awareness about vaccination, growing government funding for vaccination programs and increasing prevalence of infectious diseases drive the growth of the Tuberculosis Vaccine Treatment Market. Furthermore, improving healthcare infrastructure and emphasis on prevention of diseases drive the growth of Tuberculosis Vaccine Treatment Market.
According to Centers for disease control and prevention, One third of the world’s population is infected with TB. In 2016, 10.4 million people around the world became sick with TB disease. There were 1.7 million TB-related deaths worldwide. A total of 9,272 TB cases (a rate of 2.9 cases per 100,000 persons) were reported in the United States in 2016.
However, on the other hand, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the Tuberculosis Vaccine Treatment Market.
Intended Audience
- Research and Development (R&D) Companies
- Government and Independent Research Laboratories
- Tuberculosis Vaccines Manufacturers
- Tuberculosis Vaccines Suppliers
- Government and Independent Regulatory Authorities
- Academic Medical Institutes and Universities
Tuberculosis Vaccine Treatment Market Segmentation
Tuberculosis vaccine treatment market is segmented on the basis of types of test, type of TB vaccines, and end users.
On the basis of type of test, it is segmented into tuberculin skin test (TST), TB blood tests, IGRAs (interferon-gamma release assays), and others.
On the basis of type of Tb vaccines, it is segmented into immunotherapeutic vaccines, booster vaccines, and others.
And on the basis of end users, it is segmented into hospitals, private clinics, research institutes, and others.
Tuberculosis Vaccine Treatment Market Regional Analysis
On the regional basis, the tuberculosis vaccine treatment market is segmented into America, Europe, Asia Pacific and the Middle East & Africa.
America holds the largest market share of TB vaccines due to the major market players are concentrated and its emphasis on vaccination against TB.
Europe accounts for the second largest market for TB vaccines; this is due to increase in research and development activities by research institutions and pharmaceutical companies. According to UK TB statistics reports, in 2016 there were 5,664 TB cases 39% of cases were in diagnosed in London and 3.8% of people with TB were also living with HIV.
Asia Pacific is expected to be the fastest growing market for Tuberculosis vaccines market over the forecast period. India and China are expected to be emerging and fastest growing countries in this regional market.
According to WHO, India accounts with the highest burden of TB. In 2015, an estimated incidence of 2.84 million cases of TB in India.
On the other hand, The Middle East and Africa holds least market share due to limited screening, ignorance of diseases, and poor access to treatment.
Tuberculosis Vaccine Treatment Market Key Players
- Merck & Co., Inc.(US)
- Sanofi Pasteur SA (France)
- Serum Institute of India Pvt. Ltd. (India)
- GlaxoSmithKline plc (UK)
- IDT Biologics GmbH
- GreenSignal Bio Pharma Limited (India)
- Taj Pharmaceuticals Limited (India)
- Bavarian Nordic(US)
- Solvay(US)
- Informa plc.(US)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
